Oslo, Norway

Hans Jacob Ronold

This inventor holds 1 USPTO granted patent. Top assignee: Astra Tech Ab. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Hans Jacob Ronold: Pioneering Biocompatible Implants

Introduction: Hans Jacob Ronold, a distinguished inventor based in Oslo, Norway, has made significant contributions to the field of biomedical engineering. With a focus on enhancing the biocompatibility of implants, Ronold's work stands out in the medical device industry.

Latest Patents: Ronold holds a patent for "Implants with Modified Surfaces for Increased Biocompatibility, and Method for Production Thereof." This innovative implant features a surface modified for improved biocompatibility, primarily composed of titanium, zirconium, hafnium, or tantalum, with titanium being the preferred choice. The modified outer layer includes a hydride of the chosen metal, providing enhanced functionality. The method for producing such an implant is also part of this groundbreaking patent.

Career Highlights: Hans Jacob Ronold's career is marked by his dedication to developing advanced medical solutions. Working at Astra Tech AB, he has leveraged his expertise in materials science to create implants that significantly improve patient outcomes. His singular patent highlights his commitment to innovation in the healthcare sector.

Collaborations: Throughout his career, Ronold has worked alongside talented colleagues, including Jan Eirik Ellingsen and Ketil Videm. Their collective efforts have contributed to refining and advancing the technologies involved in biomedical applications.

Conclusion: Hans Jacob Ronold's contributions to the field of biocompatible implants are noteworthy, underscoring the importance of innovation in healthcare. His patented work reflects a commitment to improving the quality of life for patients through advanced medical technologies. As he continues his endeavors, the potential for further breakthroughs remains promising.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…